Serotonin syndrome with mirtazapine-fluoxetine combination.
F
F
Benazzi
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D003863:Depression / Q000188:drug therapy; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D008803:Mianserin / Q000009:adverse effects / Q000031:analogs & derivatives*; D000078785:Mirtazapine; D020230:Serotonin Syndrome / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
D000317:Adrenergic alpha-Antagonists; D000929:Antidepressive Agents, Tricyclic; D005473:Fluoxetine; D008803:Mianserin; D000078785:Mirtazapine; D017367:Selective Serotonin Reuptake Inhibitors